Wednesday, February 1,
2012 – Before Market
Open
New Green Baron “Stock
Alert”
Heartland Bridge
Capital, Inc.
(BB: HLBC - $3.00 per
share)
www.HeartlandBridgeCapital.com
Common Shares
Outstanding: 16,451,452
Market Cap: $49.35M
52-Week High: $3.27
52-Week Low: $2.00
Average Price: $3.112
(50-day) $3.0129
(200-day)
Heartland Bridge Capital
Provides Investors the
Best of Both Worlds
Veteran Management Team
Formed to Build
Investment and Operating
Company Akin to
Berkshire Hathaway
Grass Roots Distribution
Initiates Coverage with
Six-Month $6.30 Price
Target through 45-page
Research Report
Click to View Report
Recent News
–
Heartland Bridge Capital
Signs LOI to Purchase
25% of Legends and
Heroes, Inc.
The Green Baron Believes
HLBC can More than
Double Over the
Near-Term
The Green Baron Report
has selected Heartland
Bridge Capital, Inc. (OTCBB:
HLBC) as our newest
Green Baron “Stock
Alert”,
and we strongly suggest
members accumulate the
stock as close to our
profile price as
possible. Results
compiled from the most
recent trade prior to
dissemination of this
report to the subsequent
high will be closely
monitored at
www.thegreenbaron.com
and through email
updates to members. We
have very aggressive
price projections for
HLBC and believe the
stock has huge upside
potential based on
several positive
fundamental factors.
TRADER’S NOTES:
HLBC is current in its
SEC filings and trades
on the OTCBB. HLBC has
been slowly building
activity and price
improvement over the
past several months
under a tight float.
The Company appears to
be on the verge of a
breakout as developments
confirm its business
plans are being met.
Heartland Bridge
Capital, Inc., (“HBC”),
organized in late 2010,
is a public company that
will serve the financial
and other needs of
emerging companies run
by
exceptionally talented
entrepreneurs
and operating executives
who are dedicated to
creating positive change
in our world. HBC will
function as an
investment and operating
company, broadly akin to
Berkshire Hathaway or
other private equity
firms, focused primarily
on providing equity,
acquisition debt, or
bridge financing
to emerging high-growth
companies and
entrepreneurs.
Additionally, HBC will
supplement the
capabilities of its
investment companies in
non-financial areas to
help them achieve their
potential, thereby
maximizing the value of
the investment for HBC’s
shareholders.
As a new firm, HBC has a
distinct advantage
relative to most
existing private equity
firms – the lack of a
“legacy.” As a new
company, HBC does not
have the burden of
having to deal with –
from both a financial
and a managerial
perspective – the
challenges resulting
from having made
investments during the
inflated valuation
environment of 2005 to
2007. Instead, HBC has
the opportunity to
benefit from the
depressed market of
today – and history
shows that private
equity investments made
during times of market
distress have produced
the best returns.
The Green Baron Report
has identified the
following primary
reasons for accumulation
of HLBC now:
-
The Next Berkshire
Hathaway?
– Along
with its operating
assets, HBC
functions as a
holding and
investment company,
broadly akin to
Berkshire Hathaway
or other such
private equity
firms, focused
primarily on
providing equity,
acquisition debt, or
bridge financing to
emerging high-growth
companies and
entrepreneurs. We
view this as a
ground floor
opportunity to own
shares in a new
private equity firm
that is positioned
to own a large
percentage of great
companies at a very
attractive entry
level.
-
Best of Both Worlds
- HBC is organized
to offer investors
an opportunity to
participate in
investments with the
potentially
attractive
risk/reward profiles
sought by hedge
funds, but at an
investment level
that is manageable
for the everyday
investor. As a
result of being a
public company,
making an investment
in HBC does not
require the investor
to commit a large
amount of capital;
in this manner, the
pool of investor
participants will be
“inclusive” rather
than “exclusive” –
thus achieving one
of the primary goals
of the founders of
HBC.
-
Investment in Legend
and Heroes, Inc.
- Legends & Heroes,
Inc. is the owner of
Skineez, and the
developer and
marketer of Skineez
Skincarewear™, a
unique and exciting
brand of
doctor-approved
cosmetotextile
garments.
Cosmetotextiles are
fabrics equipped
with patented
microcapsules that
impart skin care
benefits, combat
aging, and promote
overall health and
wellness. Operating
in the space where
pharmaceutical and
beauty care products
are converging;
Skineez is tapping
into a $5 billion US
market. Skineez has
a revolutionary
technology for
treating fabrics
with microcapsules
that contain
cosmetic ingredients
that form a balanced
combination of
anti-cellulite
ingredients
-
#1 Doctor
Recommended
– Skineez is the
first and only
compression garment
in the market to
state #1 doctor
recommended, and is
now aligned with
Plastic Surgeons and
Orthopedic Surgeons
endorsing Skineez.
-
Investment in
Myself®
– HLBC owns a right
to receive cash
distributions based
on the sales of the
Myself® pelvic
muscle trainer,
owned by Jarden
Corporation, the
large consumer
products company.
The Myself® pelvic
muscle trainer is
the first FDA
cleared,
non-prescription
product available
direct to the
consumer for the
treatment of female
incontinence. The
Myself® product is
also an effective
therapeutic choice
for a number of
other pelvic floor
weakness-related
conditions affecting
millions of women.
-
Investment in
Medical Applicator
– HLBC owns assets
that include a
patent application
for a novel medical
applicator that is
capable of
delivering medicants
and internal devices
within the body in
an atraumatic
fashion (without
producing injury or
damage). The medical
applicator
technology has a
number of potential
uses in the medical
device field.
-
Cohen Price Index
Target $6.30
– In a 45-page
research report
issued by Grass
Roots Research and
Distribution last
summer, a price
target was set at
$6.30 per share.
Now that HLBC has
begun to
aggressively
implement its
business plan, we
believe that this
target is now
attainable as recent
news and
developments
indicate marked
progress is being
made on several
fronts.
Green Baron Analysis
A Company like this is
all about the
management. We believe
Heartland Bridge Capital
has assembled a high
quality, veteran group
of experienced
professionals to the
table to target the best
investment opportunities
available. Due to the
financial collapse in
2007 and continued
challenges for small
companies to raise cash,
there are opportunities
for investment that are
among the best in
history.
The investment
philosophy and focus of
HLBC appears sound.
Management has targeted
the market sectors most
likely to provide the
combination of
sufficient investment
choices and attractive
returns.
The Green Baron Report
believes HLBC stock will
positively react to
developments as they are
made public, and a move
to over $6.00 per share
over the next six months
is certainly attainable.
About Heartland Bridge
Capital, Inc.
Heartland
Bridge Capital, Inc.
(OTCBB:HLBC) is a public
company that, in
addition to managing its
own operating entities,
participates in emerging
companies run by
exceptionally talented
entrepreneurs and
operating executives who
are dedicated to
creating positive change
in our world. HLBC will
function as an owner,
product developer, and
investor focused
primarily on providing
equity, acquisition
debt, or bridge
financing to emerging
high-growth companies
and entrepreneurs in the
areas of clean energy,
waste management, and
life sciences.
www.heartlandbridgecapital.com.
To request an investor
packet on Heartland
Bridge Capital register
online at
www.wallstreetnewscast.com/request/hlbc.html
Investment Philosophy –
The Opportunity
Numerous studies have
described the challenge
faced by emerging
technology and clean
energy companies to find
an appropriate source of
finance – whether
project or corporate –
for early commercial
scale production and
projects. In
combination with the
hurdles involved in
organizing the necessary
managerial, financial,
and other skills, the
all-too-often result is
that many promising and
potentially viable –
even highly valuable –
technologies never
become commercial.
This challenge, faced by
virtually all emerging
companies and generally
characterized as the
“Valley of Death”,
provides an enormous
investment potential for
HBC – a “Mountain of
Opportunity.”
The investment
opportunity for HBC, and
the potential benefit
for investors in HBC, is
further enhanced by HBC
being a new investment
vehicle. As a new fund,
HBC does not have the
burden of having to deal
with – from both a
financial and a
managerial perspective –
the challenges resulting
from troubled or
sub-performing
investments made during
the inflated valuation
environment of 2005 to
2007. Instead, HBC has
the opportunity to
benefit from the
depressed market of
today – and history
shows that private
equity investments made
during times of market
distress have produced
the best returns.
The Investment Focus
A combined consideration
of the expertise and
experience of HBC’s
investment professionals
and the market sectors
most likely to provide
the combination of
sufficient investment
choices and attractive
returns has resulted in
four sectors being the
intended focus of HBC’s
activities:
-
Clean Energy and
Energy Efficiency
-
Medical Technology
and Life Sciences
-
Waste Treatment and
Management
The primary focus is on
emerging businesses with
significant commercial
opportunities that also
provide a meaningful
social benefit by
improving society and
making people’s lives
better. Businesses in
such sectors as Clean
Energy and Energy
Efficiency, Medical
Technology, Waste
Treatment and
Management, and Digital
Document Management fall
within this category,
and would be in the
“sweet spot” for HBC.
Investment Portfolio
Legends & Heroes
- is a for-profit
corporation that works
with non-profits and
charitable organizations
to promote social good
52 weeks a year. Through
Skineez, Legends &
Heroes helps fund
healthcare to the
underinsured and
uninsured; through
Clothes for Cause, it
supports breast cancer
and heart disease
prevention, education,
and treatment for women,
as well as a wide range
of other socially
conscious charities,
including 'NSYNC's
Challenge For The
Children, the Magic
Johnson Foundation, the
Banner of Hope, and The
Big Bam!
www.legendsandheroes.com,
www.myskineez.com;
www.vitawear.net;
www.clothesforacause.com
Myself® – HLBC
owns a right to receive
cash distributions based
on the sales of the
Myself® pelvic muscle
trainer, owned by Jarden
Corporation, the large
consumer products
company. The Myself®
pelvic muscle trainer is
the first FDA cleared,
non-prescription product
available direct to the
consumer for the
treatment of female
incontinence. Myself® is
a home-use biofeedback
product that allows a
woman to successfully
utilize Kegel exercises
to strengthen her pelvic
floor muscles on her
own. In addition to
urinary incontinence,
the Myself® product is
an effective therapeutic
choice for a number of
other pelvic floor
weakness-related
conditions affecting
millions of women.
www.themyselftrainer.com
Jarden Corporation,
directly or through
affiliates, is the owner
of the Myself® pelvic
muscle trainer and has
multiple international
and domestic patents for
the product. Jarden also
maintains a registered
trademark for the name
“Myself” for medical
devices, namely, a
muscle activity
measuring device for use
in the treatment of
pelvic floor dysfunction
in women in the United
States.
HepatoChem – HLBC
has entered into a
definitive investment
agreement with
HepatoChem, Inc., an
exciting new company
based in Cambridge, MA,
that offers
pharmaceutical and
biotech companies
reliable and efficient
access to small molecule
metabolites in
quantities needed in the
drug development
process. HepatoChem's
innovative technology
uses biomimetic
catalysts to mimic the
metabolic function of
the liver.
This unique technology,
developed in
collaboration with
Professor John Groves at
Princeton University,
enables the production
of metabolites faster
and with greater
cost-effectiveness than
any other available
technology.
www.hepatochem.com
HLBC’s agreement allows
for an investment by
HLBC of up to $400,000;
to date, $100,000 has
been invested.
Medical Applicator
– HLBC owns assets that
include a patent
application for a novel
medical applicator that
is capable of delivering
medicants and internal
devices within the body
in an atraumatic fashion
(without producing
injury or damage). The
medical applicator
technology has a number
of potential uses in the
medical device field.
The use of the
applicator technology as
a vaginal tampon
delivery device offers
the largest and
nearest-term commercial
potential due to its
large consumer market
and is the first
potential product being
examined.
A development team is
currently working to
refine the design
criteria and market
parameters for the
project, which will help
them to create clinical
testing prototypes of
the delivery device in
its tampon applicator
form. The tampon
applicator under
development is designed
to replace the plastic
and cardboard
applicators currently
used by women to insert
tampons. Targeted
advantages for the new
applicator include
easier and pain-free
insertion, superior
disposability
(flushable/
biodegradable), and
smaller size at a cost
equal to or less than
current plastic
applicators. Prototype
development is underway.
Recent Key Press
Releases
Thursday, January 19,
2012 –
SKINEEZ Health and
Wellness Apparel Line
Seeks to Revolutionize
the Garment Industry
-
MAHWAH, N.J., Jan. 19,
2012 /PRNewswire/ --
Skineez™ Skincarewear™,
an investment holding of
Heartland Bridge
Capital, Inc. (OTCBB:
HLBC), seeks to
revolutionize the
garment industry with
their unique health and
wellness apparel product
line.
SKINEEZ™ Skincarewear™
are comfortable and
highly effective
garments that constantly
deliver healthy and
natural cosmetic
ingredients to your skin
while you wear them.
Skineez is proven to
reduce inches and firm
loose skin without diet
and exercise, and are so
comfortable, they can be
worn to bed or for any
occasion in your busy
work and leisure
lifestyle.
Unique Technology
SKINEEZ SKINCAREWEAR™
garments are a whole new
dimension in women's
apparel, and feature a
patented new technology
that weaves the garments
with microcapsules that
moisturize and smooth
your skin while you wear
them. Each microcapsule,
designed to protect the
ingredients inside, is a
balanced combination of
anti-cellulite
ingredients (retinol,
caffeine, red algae
extract) with
natural-based
moisturizing ingredients
(shea butter, apricot
kernel oil, rose hip
oil, vitamin E).
The special fabric is
treated with the
microcapsules during the
manufacturing process.
When the garment is
worn, the body's heat
and the friction from
wearing the garment
slowly release the
patented embedded
cosmetic ingredients
onto the skin. The
garment can be
replenished after
washing up to 10 times
with the SKINEEZ
slimming spray.
James F. Groelinger, CEO
of Heartland Bridge
Capital, commented:
"With the success in
recent years of such
active wear and under
garment companies such
as Under Armour and
lululemon, our
investment partnership
with Legend & Heroes,
the owners and operators
of the Skineez health
and wellness apparel
brand, sets the stage
for Heartland to benefit
from continued attention
and expansion in this
market, including the
expansion into 3,700
pharmacies later this
spring and ongoing
celebrity endorsements."
For more information on
SKINEEZ SKINCAREWEAR™
please visit
www.myskineez.com
Friday, December 9, 2011
–
Heartland Bridge Capital
Expands Portfolio with
Investment in Legends
and Heroes, Inc. -
Heartland Bridge
Capital, Inc. (OTCBB:
HLBC), a private equity
firm focused on
developing a portfolio
of unique investments in
emerging technologies,
announced that it has
entered into a Letter of
Intent with, and has
taken an equity stake
through its initial
investment into, Legends
& Heroes, Inc.
Legends & Heroes, Inc.
is the owner of Skineez,
and the developer and
marketer of Skineez
Skincarewear™, a unique
and exciting brand of
doctor-approved
cosmetotextile garments.
Cosmetotextiles are
fabrics equipped with
patented microcapsules
that impart skin care
benefits, combat aging,
and promote overall
health and wellness.
Operating in the space
where pharmaceutical and
beauty care products are
converging; Skineez is
tapping into a $5
billion US market.
Skineez has a
revolutionary technology
for treating fabrics
with microcapsules that
contain cosmetic
ingredients that form a
balanced combination of
anti-cellulite
ingredients (retinol,
caffeine, red algae
extract). Legends &
Heroes, headquartered in
Newton, MA , is entering
a period of major market
expansion and welcomed
the investment from
Heartland, which it
perceived as sharing in
one of its core values:
"Doing Good!"
Terms of the agreement
and investment structure
are included in an SEC
8K filing of December 7,
2011.
James F. Groelinger, CEO
of Heartland Bridge
Capital, commented: "We
are very excited to be
able to make this
investment in L&H at a
time that supports the
impending commercial
emergence of the Skineez
product line. The
technical aspects of the
product fit well with
the overall objectives
of Heartland's Life
Sciences strategic
focus, and represent an
opportunity to
participate in a new
market segment in which
we expect to see rapidly
accelerating growth."
Michelle Moran, L&H's
CEO, said: "We were
introduced to Heartland
and immediately felt the
potential for a
synergistic
relationship. Faced with
the challenge of
addressing the explosive
market opportunities
that are opening up for
us, the ability to
structure a transaction
that provided immediate
cash, with a second
phase of additional cash
and Heartland
securities, was
attractive. I found
Heartland to be
insightful and enjoyable
to work with, as well as
an attractive investment
vehicle in its own
right. I'm looking
forward to closing on
the second part of our
arrangement and to
having a fruitful
long-term relationship."
One of the most unique
features of Skineez
Skincarewear™ is its
longevity. The special
fabric is treated with
the microcapsules during
the manufacturing
process. When the
garment is worn, the
body's heat and the
friction from wearing
the garment slowly
release the patented
embedded cosmetic
ingredients onto the
skin. However, unlike
similar garments that
have been on the market
in Europe for some
years, the Skincarewear™
garment can be
replenished after
washing up to 10 times
with the SKINEEZ
slimming spray. This
greatly enhances the
user experience and
economics.
Management Team
James F. Groelinger
is the Chairman,
President, and Chief
Executive Officer of HBC.
Jim has extensive
international corporate
and business management
experience with a strong
focus on business
development and value
creation in all aspects
of the energy field. He
is also the Executive
Director of the Clean
Energy Alliance, Inc., a
national network of
clean energy business
incubators.
Frederick Larcombe
is HBC’s Chief Financial
Officer. Frederick has
more than thirty years
of diversified
experiences in life
sciences, medical
devices, entertainment,
manufacturing, and
professional services.
He is experienced in
raising capital,
strategic planning and
analysis, operating
company management,
intellectual property
litigation,
re-organization and
turn-around situations,
business acquisition and
integration, SEC
reporting, and investor
relations.
Wayne LeBlanc
is HBC’s Executive Vice
President for Business
Development. He has
over 25 years of diverse
experience in sales and
marketing in both large
and small businesses,
specializing in
conducting evaluations
and needs analyses for
new or increased market
penetration. He has
extensive experience in
the fields of
electricity, clean and
renewable energy, and
medical devices, all of
which fit in well with
the business strategy of
HBC.
Frederick A. Voight
is the Managing
Director, Investments
for HBC. Fred has been
the Managing Director
of a private investment
fund since1994, during
which time it has made
successful investments
in numerous companies
and products. Mr.
Voight has more than
twenty years of
experience in managing
these types of
investments. He has
previous experience as
the Chairman and CEO of
a public company and has
served as a director of
several public and
numerous private
companies.
Advisory Board
HBC has commenced the
organization of an
Advisory Board that will
comprise experts in each
of the business sectors
of primary interest to
HBC. The Advisory Board
will provide HBC's
management with
independent and informed
views of industry
trends, and will
recommend and review
investment
opportunities, both
prior to an investment
and in the course of
managing the investment
once it has been made.
The first appointment to
the Advisory Board is
Dr. Magdy Abdel-Malik, a
highly reputed corporate
innovation leader with
extensive R&D and
business development
experience. This
experience, combined
with an unwavering
commitment to innovative
thinking, aimed at
implementing the
strategic vision needed
to source, acquire, and
commercialize
best-in-class life
science emerging
technologies will help
accelerate HBC’s ability
to properly evaluate and
consummate investment
opportunities in the
medical technology area
of interest.
Contact
Tom Bustamante,
Investor Relations
Counsel
Ludlow Capital, Inc
Phone: (347) 483-0121
Email:
ludlowcapital@aol.com
